Categories AlphaGraphs, Earnings, Technology

CMCSA Earnings: A snapshot of Comcast’s Q2 2023 report

Comcast Corp. (NASDAQ: CMCSA) has reported a sharp increase in adjusted earnings for the second quarter of 2023 when the telecommunications company’s revenues rose modestly.

Comcast Q2 2023 earnings infographic

Total revenues moved up 2% annually to $30.5 billion in the June quarter. Revenues of the Connectivity & Platforms segment remained broadly unchanged, while Content & Experiences revenue moved up 4%.

Adjusted earnings increased 12% year-over-year to $1.13 per share during the three-month period. Net income was $4.25 billion or $1.02 per share, compared to $3.40 billion or $0.76 per share in the prior-year quarter.

The consistent investments we’ve been making in our growth businesses continue to generate strong results and position us extremely well both now and into the future. Second quarter operational and financial performance was excellent and included a double-digit increase in Adjusted EPS and significant free cash flow generation,” said Brian Roberts, Comcast’s CEO.

Prior Performance

  • Comcast Q4 2022 earnings infographic


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight